ERS Statement: A core outcome set for clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations

A. Mathioudakis, F. Abroug, A. Agusti et al.

Source: Guideline 2021
Number: 2021

Full text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Mathioudakis, F. Abroug, A. Agusti et al.. ERS Statement: A core outcome set for clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations. Guideline 2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016

Comparison of patient-reported outcomes (PROs) during acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016


Recommendations of the ATS/ERS Task Force for the definition of outcomes for COPD pharmacological trials
Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers
Year: 2006


Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 243-244
Year: 2002


A pilot study to assess the efficacy of breathlessness plans for patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016

Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol
Source: ERJ Open Res, 6 (3) 00193-2020; 10.1183/23120541.00193-2020
Year: 2020



Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD
Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers
Year: 2006


Chronic obstructive pulmonary disease (COPD) assessment service: guidelines for referral and accuracy of clinical assessment
Source: Eur Respir J 2005; 26: Suppl. 49, 299s
Year: 2005

Optimizing chronic obstructive pulmonary disease (COPD) diagnosis and management to reduce healthcare costs: Systematic review and modeling
Source: Annual Congress 2013 –Health economics of airway diseases
Year: 2013


Acute exacerbations of chronic obstructive pulmonary disease: current recommendations review and quality of evidence analysis.
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020

Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations.
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018

Comprehensive care programme for patients with chronic obstructive pulmonary disease (COPD) --- A randomized controlled trial (RCT)
Source: International Congress 2015 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2015

Use of telehealth in the management of patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases
Source: International Congress 2014 – Markers
Year: 2014


Diagnosis of chronic obstructive pulmonary disease (COPD) - are guidelines being implemented in primary care?
Source: Eur Respir J 2001; 18: Suppl. 33, 347s
Year: 2001

Optimal assessment and management of chronic obstructive pulmonary disease (COPD)
Source: Guideline 1995
Year: 1995

Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Variability in clinical practice for chronic obstructive pulmonary disease in outpatient clinics
Source: International Congress 2015 – Different data in COPD
Year: 2015

Clinical and economical impact of exacerbations of chronic obstructive pulmonary disease (COPD): A two-year study
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011

An evaluation of the validity of two measurements of dyspnoea as outcomes of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 182s
Year: 2002